Financial Highlights and Market Update

Rest of the World Markets 8 Strong momentum during the first quarter in line with our focus on increased contribution from Rest of the world markets sales as was observed in FY21 Q1 FY22: Rs. 2,227 Mn YoY Growth: 51% ■This has been driven by new partnerships and increased penetration geographically ■ We also initiated registration of new products such as Ertapenem in the LatAm region Rest of the World Markets Our existing portfolio is seeing strong demand from new partnerships entered in to during the year, on account of our ability to respond to the changing market demand during COVID-19 Q1 FY21 Revenue Contribution 17% Q1 FY22 19% GLAND

View entire presentation